SynthesisAging clinical and experimental research2025

Romosozumab adverse event profile: a pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) from 2019 to 2023.

Luyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.